Article ID Journal Published Year Pages File Type
10963922 Vaccine 2015 5 Pages PDF
Abstract
HAV and HBV antibodies in half or more of this young PWID population did not have levels indicative of protection, and about a quarter had HCV infection, putting them at risk for complications resulting from co-infection with HAV or HBV. Programs serving this population should vaccinate PWIDs against HAV and HBV and not rely on self-report of vaccination.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , ,